Inhibition of the TLR4/NF-κB pathway by curcumin nanoparticles (CNPs) to inhibit microglia polarization has been reported for the treatment of neuroinflammation in Alzheimer’s disease [125]. This evidence concerns the gene NFKB1 and early-onset autosomal dominant Alzheimer disease.